California Public Employees Retirement System Aerie Pharmaceuticals Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$15.16 - $18.97 $1.14 Million - $1.43 Million	-75,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$13.12 - $20.9 $91,013 - $144,983	-6,937 Reduced 8.43%	75,400 $1.35 Million
Q4 2020 Feb 02, 2021	BUY	$9.12 - $14.49 $48,673 - $77,333	5,337 Added 6.93%	82,337 $1.11 Million
Q3 2020 Nov 05, 2020	BUY	$10.46 - $14.46 $29,288 - $40,488	2,800 Added 3.77%	77,000 $906,000
Q2 2020 Aug 12, 2020	SELL	$12.0 - $16.13 $141,600 - $190,334	-11,800 Reduced 13.72%	74,200 $1.1 Million
Q1 2020 May 12, 2020	SELL	$11.84 - $25.52 $21,312 - $45,936	-1,800 Reduced 2.05%	86,000 $1.16 Million
Q4 2019 Jan 27, 2020	BUY	$17.72 - $25.1 $310,100 - $439,250	17,500 Added 24.89%	87,800 $2.12 Million
Q3 2019 Oct 31, 2019	BUY	$18.41 - $28.0 $795,312 - $1.21 Million	43,200 Added 159.41%	70,300 $1.35 Million
Q2 2019 Aug 15, 2019	BUY	$28.97 - $48.21 $63,734 - $106,062	2,200 Added 8.84%	27,100 $801,000
Q1 2019 May 03, 2019	SELL	$36.32 - $49.25 $14,528 - $19,700	-400 Reduced 1.58%	24,900 $1.18 Million
Q4 2018 Feb 08, 2019	SELL	$33.0 - $60.04 $289,509 - $526,730	-8,773 Reduced 25.75%	25,300 $913,000
Q3 2018 Nov 13, 2018	SELL	$56.15 - $73.9 $59,799 - $78,703	-1,065 Reduced 3.03%	34,073 $2.1 Million
Q2 2018 Aug 15, 2018	BUY	$47.85 - $70.45 $140,583 - $206,982	2,938 Added 9.12%	35,138 $2.37 Million
Q1 2018 May 11, 2018	BUY	$51.15 - $61.0 $1.65 Million - $1.96 Million	32,200 New	32,200 $1.75 Million
Q4 2017 Feb 06, 2018	SELL	$50.85 - $65.1 $382,646 - $489,877	-7,525 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$48.6 - $60.1 $365,715 - $452,252	7,525	7,525 $366,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account